High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.

High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.

Item
http://www.wikidata.org/entity/Q42275113
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokiStem-cell transplant preparative regimens.High-dose chemotherapy and autologous stem cell transplantation for breast cancer.A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells.High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer.Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer.High-dose etoposide in allogeneic stem cell transplantation.Hematopoietic progenitor cell transplantation in breast cancer: current status and future directions.High-dose mitoxantrone and cyclophosphamide without stem cell support in high-risk and advanced solid tumors: a phase I trial.Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.
P2860

High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.

Item
http://www.wikidata.org/entity/Q42275113
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@en
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@nl
type
label
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@en
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@nl
prefLabel
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@en
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@en
P2093
P2860
P304
P31
P356
10.1002/1097-0142(19940315)73:6<1678::AID-CNCR2820730621>3.0.CO;2-U
P407
P433
P478
P577
P698